Sunday, Nov. 22, 2026 A Vik Media Group publication
Mongevity Longevity in Motion
Leer en español

Lab test identifies the cause of a severe red skin disease more often than exams

☕ Includes a question for the family ↓

Skin diseasesPart of a story we are following · 8 articles · See every update
A number of umbrellas on the empty beach of Scheveningen on a beautiful, sunny day.
A number of umbrellas on the empty beach of Scheveningen on a beautiful, sunny day.Photo: MatteoNL97 / Wikimedia Commons, CC BY 4.0

If you or someone you love ever has a severe skin disease that turns most of the body red and scaly, the first question is always the same: what is causing it? Doctors often struggle to answer that, and the answer decides the treatment. A new study points to a more accurate way to get it.

In a study of 96 people with widespread red, scaly skin, plus 20 people with healthy skin, a computer method that read proteins and genes in skin samples identified the underlying skin disease correctly 73.9% of the time. Blinded expert exams, which combine a doctor’s look at the patient with the microscope findings, got it right 59.5% of the time.

How the study worked

Researchers took small skin biopsies from 96 people at four medical centers. The biopsies came from five different conditions that can all cause widespread red skin. They measured thousands of proteins and genes in each sample and trained a computer program to tell the conditions apart. The results were published in the Br J Dermatol on November 19, 2026. The authors call it a proof of concept, so the test needs more work before it reaches everyday clinics.

What is erythroderma?

Erythroderma is the medical name for redness and scaling that covers more than 90% of the skin. It is an acute, inflammatory condition that can be life-threatening, with death rates up to 9%. Many different skin diseases can cause it, and they look very much alike. Even under the microscope, they are hard to tell apart.

That matters because a delay in finding the cause delays the right treatment. The study authors note this can have serious effects, both right away and in the long run.

What they found

The five conditions were pityriasis rubra pilaris (PRP, 19 people), psoriasis (18), atopic dermatitis, the common form of eczema (20), cutaneous T-cell lymphoma, a cancer of immune cells in the skin (18), and a rash caused by a drug reaction (21).

The team measured more than 9,300 proteins and 17,200 genes’ worth of activity. Each condition had its own molecular signature. Here is what stood out:

  • Eczema: a protein called Charcot-Leyden crystal protein was higher. It links to a type of allergy-related inflammation.
  • PRP: a signal called IL-17C was higher, along with related inflammation signals. Only some people with PRP showed this pattern. That suggests PRP may come in different types that could respond to different treatments.
  • Skin lymphoma: a protein called RASAL3 was higher. It had not been studied before in this disease.

Then came the test itself. The computer program, called ADAPT-Mx, picked the right condition in about 74% of cases in a group of samples it had never seen before. The exact figure was 73.9%. Blinded experts using the standard approach got about 60%, or 59.5%. It was most reliable in telling each condition from the others, and it worked on each sample alone.

That is a clear step up. It is also not perfect, so it still got a share of cases wrong.

What you can do today

Nothing about your care changes today, because this test is not yet something you can request. What you can do is know the sign. If red, scaly skin spreads across most of your body, get seen by a doctor quickly and ask what is causing it. A delay in finding the cause can delay targeted treatment.

For clinicians and researchers

Design: Multi-omic diagnostic study using mass spectrometry proteomics and RNA sequencing on formalin-fixed, paraffin-embedded skin biopsies from 96 patients with erythroderma (pityriasis rubra pilaris n=19, psoriasis n=18, atopic dermatitis n=20, cutaneous T-cell lymphoma n=18, drug-induced maculopapular rash n=21) and 20 healthy controls, from four centers.

Main result: The machine-learning classifier ADAPT-Mx reached 73.9% diagnostic accuracy in the held-out test cohort, versus 59.5% for blinded clinico-histopathological assessment, with AUC values of 0.87-1.00 across disease entities.

Main limitation: Accuracy of 73.9% leaves a substantial share of misclassified cases, and the abstract reports a held-out test cohort without independent external validation or a stated test-set size; the work is a proof of concept.

Open question: Whether the classifier performs prospectively in routine practice, and whether the PRP subset with the IL-17C signature responds differently to targeted treatment, remain to be tested.

Talk about it at home

Some skin diseases turn the skin red and scaly all over, and they can look so alike that even doctors have trouble telling them apart. It is like cakes that look the same on the outside but were baked from different recipes. So scientists took tiny skin samples, read the proteins and genes inside, and taught a computer to spot the pattern each disease leaves behind.

Question for the table

The experts in this study did not know the right answer ahead of time, and the computer was tested on skin samples it had never seen before. Why do you think that makes the contest fairer, the way a guessing game with a wrapped gift is only fun if nobody peeked?

Keep exploring

Copies this article and its questions so you can paste them into ChatGPT, Claude, Gemini or the AI you use, and keep the conversation going.

Got a question? Ask us ›

Get the best of longevity science by emailThe most useful new studies, in plain language and with the source. Free.

We'll email you once to confirm. Occasional messages from our sponsors, clearly labeled. Unsubscribe anytime. We never ask for health data.
Cite this article
AMA
Mongevity Desk. Lab test identifies the cause of a severe red skin disease more often than exams. Mongevity. Published November 19, 2026. Accessed November 22, 2026. https://mongevity.science/skin/2026/11/lab-test-diagnose-erythroderma-skin-disease/
Vancouver
Mongevity Desk. Lab test identifies the cause of a severe red skin disease more often than exams [Internet]. Mongevity; 2026 Nov 19 cited 2026 Nov 22]. Available from: https://mongevity.science/skin/2026/11/lab-test-diagnose-erythroderma-skin-disease/
APA
Mongevity Desk. (2026, November 19). Lab test identifies the cause of a severe red skin disease more often than exams. Mongevity. https://mongevity.science/skin/2026/11/lab-test-diagnose-erythroderma-skin-disease/
For your website
<a href="https://mongevity.science/skin/2026/11/lab-test-diagnose-erythroderma-skin-disease/">Lab test identifies the cause of a severe red skin disease more often than exams</a>

Free to share or quote with credit and a link.

Questions and answers

What is erythroderma?
It is redness and scaling over more than 90% of the skin. Several different skin diseases can cause it, and it can be life-threatening.
How accurate was the new test?
It named the right condition 73.9% of the time in samples it had not seen before. Blinded expert exams got 59.5%.
Can I get this test now?
Not yet. The authors describe it as a proof of concept that could support doctors' decisions in the future.
Which conditions did the study cover?
Pityriasis rubra pilaris, psoriasis, atopic dermatitis, cutaneous T-cell lymphoma and a drug-induced rash.

Sources

  1. Br J Dermatol: Multi-Omic Profiling for Molecular Diagnosis of Erythrodermic Skin Diseases (PMID 43056227 · DOI 10.1093/bjd/ljag505) · 2026-11-19

More on this story

Report an error